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Proteome adaptation in cell reprogramming
proceeds via distinct transcriptional networks
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Sean M. Grimmond5, Andras Nagy3,6,7, Javier Munoz1,2,w & Albert J.R. Heck1,2
The ectopic expression of Oct4, Klf4, c-Myc and Sox2 (OKMS) transcription factors
allows reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). The
reprogramming process, which involves a complex network of molecular events, is not yet
fully characterized. Here we perform a quantitative mass spectrometry-based analysis to
probe in-depth dynamic proteome changes during somatic cell reprogramming. Our data
reveal defined waves of proteome resetting, with the first wave occurring 48 h after the
activation of the reprogramming transgenes and involving specific biological processes linked
to the c-Myc transcriptional network. A second wave of proteome reorganization occurs in a
later stage of reprogramming, where we characterize the proteome of two distinct pluripotent
cellular populations. In addition, the overlay of our proteome resource with parallel generated
-omics data is explored to identify post-transcriptionally regulated proteins involved in key
steps during reprogramming.
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T
he expression of a cocktail of defined transcription factors
is a well-known strategy to reprogram somatic mammalian
cells to a pluripotent state named induced pluripotent stem
cells (iPSCs)1 Several studies have demonstrated that iPSCs
resemble their embryo-derived counterpart embryonic stem cells
(ESCs) both at the functional and molecular levels2–14. Owing to
their properties, the development of iPSCs technology has a huge
impact both in basic research and clinical applications. To date,
various somatic cell types from diverse adult tissues (that is,
endoderm, mesoderm and ectoderm origins) have been
successfully reprogrammed to iPSCs1,15–18. However, the overall
frequency in which the transition to pluripotency occurs is
typically low (o1%) and requires 1–3 weeks of factors
expression. Nevertheless, as shown by others, the kinetics and
efficiency of this process can be manipulated by either controlling
the expression of specific molecular mediators19–22 or through
the use of chemical compounds23,24. Thus, understanding the
molecular mechanisms involved in cellular reprogramming may
enable the improvement of the efficiency of this process. The
molecular characterization of intermediate cellular states
occurring during the reprogramming process has so far been
poorly addressed largely due to (i) its extended latency, (ii) with
only a small subset of the starting cells becoming pluripotent and
(iii) leading to cellular heterogeneity. To overcome this limitation,
secondary expression systems with inducible polycistronic
constructs have been used25–27. These studies provide evidence
that reprogramming is a multistep process in which pluripotency
is acquired via step-wise transitions through defined
transcriptional states28, involving the early induction of cellular
proliferation and downregulation of differentiation markers,
followed by a mesenchymal-to-epithelial transition (MET)29,30.
Although these reports represent an invaluable source of
knowledge to decipher the molecular mechanisms governing
the different phases of reprogramming, the study of the dynamic
changes at the proteome level is not yet fully explored. It has been
shown that different levels of gene expression regulation (that is,
epigenetic marks, mRNA expression and non-coding RNAs) have
a synergic effect on determining the final levels of proteins31.
Genome-wide profiling of the proteome can be best approached
by mass spectrometry (MS)-based techniques, which allow the
identification and quantification of several thousands of
proteins32,33. As far as iPSCs are concerned, MS-based profiling
has been used to compare the proteomes of human iPS and ES
cells34,35. Recently, protein expression changes during
reprogramming have been investigated revealing the occurrence of
highly coordinated proteomic changes in this process36. However,
such analysis included five time points, which may have limited the
chance to capture additional stage-specific events. Moreover, the use
of pre-selected cell populations ‘on route’ to pluripotency (that is,
using specific markers such as SSEA1, Thy-1 and Oct4-GFP) might
neglect the existence of additional mechanisms arising
simultaneously in reprogramming cells. Indeed, we have
demonstrated that ESC-like cells are not the only pluripotent
outcome of the reprogramming process37. We have identified a new
category of steady-state pluripotent cells (F-class), which can appear
when the reprogramming factors are expressed at high levels37.
Here, we use our transposon-based secondary reprogramming
system27 to quantitatively probe, at an unprecedented depth, the
proteome changes of reprogramming cells in 13 different time
points. By using a dual transgene expression scheme, we isolate
two different cellular populations established in the late phase of
reprogramming (F-class and ESC-like cells) and demonstrate that
they exhibit unique proteomic features. As part of a multi-omics
joint consortium37–40, we have also investigated the presence of
post-transcriptional mechanisms that might tune final protein
levels.
Results
To profile proteome changes at different stages of somatic cell
reprogramming, we used our secondary mouse embryonic
fibroblast (2MEF) cell line (1B), generated by a doxycycline
(dox)-inducible piggyBac transposon-based transgene delivery
system27. A modulated transgene expression scheme was used to
model cell reprogramming towards the fuzzy colony-forming
state (F-class)37 and the ESC-like state. Briefly, after 16 days of
transgene expression, induced by high concentrations of
doxycyclin (high dox¼ 1,500 ngml 1), the cellular population
is dominated by cells representing the F-class state. Attenuated
transgene expression obtained by dropping the dox concentration
300-fold to 5 ngml 1 at day 8, facilitated the transition of
reprogramming cells to the ESC-like state38. Although the
Nanogþ F-class cells share some properties with the ESC-like
state (immortality, self-renewal, teratoma formation and in vitro
differentiation capability), they differ with respect to cell
morphology, transgene dependence and ability to integrate into
pre-implantation embryos and to form chimaeras37.
A total of 13 samples, representing the temporal course of
reprogramming, were subjected to in-depth quantitative proteo-
mic analysis (Fig. 1). We analysed the precursor 2MEF, six
intermediate time points (day 2, 5, 8, 11, 16 and 18) at high-dox
concentrations (termed D2H, D5H, D8H, D11H, D16H and
D18H) and three intermediate time points (day 16 and 21)
collected after reducing the doxycyclin concentration (low dox)
starting from day 8 (termed D16L, D21L, D21Ø). In addition, we
analysed the secondary iPSCs (termed 2iPSC), primary iPSCs
(termed 1iPSC) and Rosa26-rtTA transgenic ESCs, which
represent the ESC-like pluripotency (termed ESC). By using a
combination of isobaric peptide labelling, strong cation exchange
(SCX) chromatography and high-resolution tandem mass
spectrometry (LC-MS/MS) analysis, we identified a total of
7,250 proteins and quantified 4,454 of those in all the samples
analysed (Supplementary Figs 1 and 2 and Supplementary
Data 1). Importantly, 55% of the proteins quantified (n¼ 2,452)
changed more than twofold in at least one of the samples (when
compared with the 2MEF), indicating that the dox-induced
OKMS expression results in widespread proteome changes.
Using this subset of 2,452 differential proteins, we first
examined the global correlation over all the samples (Fig. 2a,
Supplementary Data 2). This analysis revealed at least six distinct
groups, (a) the precursor 2MEF, (b) the first high-dox sample
(D2H), (c) the further transient high-dox cells (D5H–D11H), (d)
F-class state (represented by D16H and D18H), (e) the low-dox
(D16L, D21L, D21Ø) samples and (f) 1iPSC, 2iPSC and ESC.
Two days following dox-induced OKMS protein expression, the
proteome was already very distinct from the original fibroblast
proteome. After that, a distinctive step-wise temporal progression
of the reprogramming process was evident in the high-dox
samples, where D5H cells displayed a high similarity with the
subsequent time points D8H and partially with D11H. Notably,
the dynamic changes observed from D2H until D11H turned into
a stable proteome state at D16H and D18H. Cells at these latter
two time points were almost indistinguishable at the proteome
level and represent the aforementioned F-class cells (Fig. 2a).
Notably, these F-class cells represent a stable state and do not
turn into an ESC-like state even after 2 additional weeks of
high-dox treatment37. However, following the reduction of
transgene expression, the population of reprogramming cells
morphologically resembled ESCs38. In agreement with these
findings, our proteomic data show that the low-dox cells (D16L,
D21L and D21Ø) share not only a high proteome correlation
between each other, but also with the ESC-like state samples
(Fig. 2a). Next, we investigated the proteomic behaviour of genes
related to pluripotency and self-renewal as reported in the
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Plurinet resource41. From the 282 Plurinet genes, our data
contained quantitative measurements for 129 proteins that we
used to assess the correlation between the different cell states.
This focused analysis revealed a lower correlation for all the
reprogramming cells with the ESC-like group, compared with the
global proteome analysis (Fig. 2a,b), which means that none of
these cells undergo a full activation of the pluripotency network.
Moreover, weak Plurinet-based correlation changes between the
2MEF and the cells exposed to high-dox conditions is evident,
while low-dox cells are clearly distinct (Fig. 2b). When compared
with ESC, the correlation of 2MEF and high-dox samples is
constantly low. In contrast, attenuated transgene expression led to
a substantial increase in similarity with the ESC-like state
(Fig. 2c).
Intrigued by these findings, we investigated which Plurinet
proteins exhibited differential expression between F-class, low-
dox and ESC-like cells. This analysis revealed that proteins
involved in nuclear processes (for example, Ncl, Lyar, Parp1,
Kpna2) and chromatin architecture establishment (for example,
Uhfr1, Kdm6a, Eed, Suz12, Smarca5, Smarcad1, Smarcc1), and
also Nanog, were expressed at comparable upregulated levels
within both pluripotent cell populations (Fig. 2d). However, in
F-class cells, several pluripotency markers (for example, Sall4,
Utf1, Dppa4, Lefty and Esrrb) were less abundant than both the
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Figure 1 | Schematic overview of the experimental proteomics workflow. Treatment of 1B 2MEF with doxycycline (1,500ngml 1)-induced OKMS
expression and initiated reprogramming, which was monitored at five consecutive time points (D2H, D5H, D8H, D11H, D16H and D18H). Modulation
of transgene expression was induced by dropping the dox concentration to 5 ngml 1 after 8 days, whereafter three samples were profiled: D16L, D21L
and D21Ø (in the latter sample, doxycycline was completely removed on day 14). In addition, the original 2MEFs, a Rosa rtTA ESC line, as well as the
primary and secondary iPSCs (1iPSC and 2iPSC) were included in our quantitative proteome analysis. All the 13 collected samples were processed for
proteomic analysis (lysis, proteolysis, TMT-based isotope labelling) and grouped in three mixtures before SCX fractionation and LC-MS/MS analysis,
whereby each mixture included a common internal standard (ISTD). Temporal expression profiles were obtained using differential quantification versus
this common ISTD.
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low-dox and ESC-like cells (Fig. 2d) (a finding supported by
transcriptomic analyses performed in parallel38).
Recently, it has been proposed that iPSCs may retain an
epigenetic memory of their parental cells42,43. Using our
reprogramming system, we have observed in F-class that the
low expression of many pluripotency genes is associated with
5-methylcytosine and H3K27me3 inhibitory marks37,38,40. In the
current data set, we found reduced levels of proteins involved in
DNA methylation (for example, Dnmt3b, Dnmt3l, Zfp57, Tet1),
telomeres binding (for example, Rif1, Terf1) and other epigenetic-
based transcriptional regulators (for example, Pml, Phf17, Jarid2
and Yy1) in F-class cells. Notably, Tet1 has been shown to replace
Oct4 and initiate somatic cell reprogramming in conjunction with
Sox2, Klf4 and c-Myc44. Moreover, although some proteins
involved in epigenetic control of gene expression (that is, Suz12
and Eed subunits of the Polycomb complex 2) were highly
expressed by F-class, low-dox and ESC-like cells, there were
two important modulators of this complex, Jarid2 and Yy1
(refs 45,46), present at a lower level specifically in F-class cells
(Fig. 2d).
The systems-level nature of our analyses allowed us to
investigate whether the reprogramming process could be to a
certain extent regulated post-transcriptionally. We compared our
protein measurements with mRNA-seq data derived in parallel38.
Throughout all time points, we observed a reasonable, albeit not
perfect, correlation between mRNA and protein changes
(Pearson’s correlation B0.5; Fig. 3a). However, the low-dox
samples exhibited a substantial lower correlation (Pearson’s
B0.25). We then selected arbitrarily the uppermost 1,275 genes,
for which protein and mRNA showed poor correlation (see
Methods) in F-class, ESC-like and low-dox cells (Fig. 3b) where
the poor correlation was particularly evident. We next categorized
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Figure 2 | Proteome adaptation occurs in waves during somatic cellular reprogramming. Pearson correlation values were calculated for all
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these 1,275 genes in four subsets on the basis of whether protein
levels displayed up- or downregulation, but no change in mRNA
and vice versa, and probed if the genes in any of these subsets
were enriched in particular GO terms (see Methods). As shown in
Fig. 3c, the data suggest that, particularly in low-dox cells, post-
transcriptional regulatory mechanisms control the expression at
the protein level of genes involved in cellular adhesion (for
example, remodelling of epithelial adherens junctions, integrin
and paxillin signalling), oestrogen and androgen signalling and
mitochondrial function. The observed downregulation of these
proteins may be controlled more intensely by ubiquitin-
dependent degradation rather than translational control.
To draw an unbiased picture of the dynamic proteomic
changes occurring at different phases of reprogramming, we next
clustered the 2,452 differential proteins on the basis of their time
course expression during the reprogramming process (from
2MEF to 2iPSC) into nine distinct profiles (Fig. 4a). For figure
legibility and better show of the temporal sequence of the
reprogramming process, we did not include 1iPSC and ESC
samples in such analysis, as these samples show similar proteome
profiles with 2iPSC (Fig. 2a). We subsequently investigated
whether the proteins within a cluster shared functionality. These
analyses revealed the involvement of specific molecular processes
in certain phases of the reprogramming process. For instance,
early proteomic changes showed a highly coordinated activation
(cluster 1 and 7) of the cellular machinery necessary to sustain
increased cellular kinetics (proteins involved in cell cycle control,
cellular proliferation, metabolism and energy production) and the
refined tuning of expression programs (RNA processing, gene
expression, nucleolar proteins) (Fig. 5 and Supplementary
Fig. 3a,b). We also found that fibroblasts rapidly lose their
cellular identity by downregulating mesenchymal markers
(clusters 3 and 8 Fig. 4b), as well as proteins related to
glycosylation, vesicle transport, extracellular matrix and energy
reserve metabolism (Fig. 5 and Supplementary Fig. 3b). Interest-
ingly, interrogation of available ChIP-seq data47 revealed that the
first wave of proteome resetting is strongly enriched for target
genes of c-Myc, Kdm5b and Jarid2a pointing out these
transcription factors as having key roles in these early events
(Fig. 5 and Supplementary Fig. 4). These findings are in
agreement with recent gene expression and proteomic analyses
in a different secondary reprogramming design restricted toward
ESC-like pluripotency28,36.
To further investigate causative or descriptive markers in the
co-occurring pluripotency routes, we focused on proteome
adaptation observed at the intermediate phase. Subtle changes
occur from D5H until D11H, whereby cells exhibit an increased
level of epithelial proteins, retinoic acid signalling and ESC-
specific adhesion molecules (Supplementary Fig. 5), consistent
with the MET that is required as one of the key processes during
fibroblast reprogramming29,30. In the late reprogramming phase,
more prominent proteome changes are observed in both F-class
and low-dox cells. F-class cells are uniquely characterized by a
coordinated loss of epithelial and ESC-specific adhesion proteins
(with the exception of Epcam) compared with D5H–D11H, low-
dox and ESC-like samples (Supplementary Fig. 5a,b). Instead,
proteins exhibiting their maximum expression in F-class cells are
associated with metabolism and cellular proliferation (cluster 1)
and are mainly regulated by the c-Myc transcriptional network
(Fig. 5 and Supplementary Fig. 4). The fact that high-dox
conditions lead to a reprogramming path characterized by an
early MET, followed by an EMT transition and an increase in
cellular metabolism is further reflected by miRNAs analysis39,
where an altered expression of pro-MET, pro-EMT and
mitochondrial RNA is observed in the same set of samples. It is
intriguing that F-class state may be linked to the activation of
specific expression programs occurring when the cells have
acquired epithelial traits. Coincidently with this phase of
reprogramming, we noticed an early and transient upregulation
of proteins involved in retinoic acid (RA) signalling (Rbp1,
Aldh1a1and Gprc5a) (Supplementary Fig. 5c). Notably, opposing
effects of RA on cell proliferation correlates to the level of two RA
binding proteins, Crabp2 and Fabp5 (ref. 48). In cells
characterized by a high Crabp2/Fabp5 ratio, RA signalling
results in the activation of RAR nuclear receptors and exhibit a
proapoptotic activity, whereas high level of Fabp5 protein results
in the activation of the nuclear receptors Pparb/d, promoting cell
survival In reprogramming cells, these two RA binding proteins
showed a sequential upregulation, with Crabp2 being upregulated
only in D8H and D11H and Fabp5 in F-class cells
(Supplementary Fig. 5c,d), possibly representing one of the
mechanisms involved in the establishment of the F-class
cell type21.
Cluster 8 contains proteins that demonstrate the highest
expression in the 2iPSC (Fig. 4a), with limited activation in
F-class cells. Several well-known ES cells markers belong to this
cluster (Fig. 4c). Functional analysis revealed a strong enrichment
for proteins involved in DNA replication, transcription regula-
tion, as well as chromatin modification (Fig. 5 and Supplementary
Fig. 3a,b). These results confirmed, at the global proteome level,
our finding that low-dox cells closely resemble the expression
level of proteins upregulated in ESC-like state (see Plurinet
analysis in Fig. 2d). Of note, we also found that the significant
proportion of proteins highly expressed in ESC-like cells are
controlled transcriptionally by Sox2, Oct4, Nanog and Chd1
(Fig. 5 and Supplementary Fig. 4). To define the common
molecular imprint between F-class and ESC-like cells controlled
by these key transcription factors, we first selected the known
target proteins of Nanog, Oct4 and Sox2 (ref. 47) found to be
upregulated in 2iPSC and ESC (Fig. 6a, Supplementary Data 3).
Next, we defined the specific subset of protein targets, which
remain silent or partially active (upregulated compared with
2MEF and downregulated compared with ESC-like) in F-class
cells (Fig. 6a) and monitored the dynamic activation of these
targets across the whole reprogramming window (Fig. 6b).
Notably, the partial activation of the ESC-like pluripotency
network in F-class cells seems to be sufficient to confer them
pluripotent traits, whereby all three germ layers can be generated
in a teratoma-forming assay37.
Although the low-dox cells closely resemble the ESC-like state
in general terms, they also exhibit a set of proteins with
abundances significantly different from the 2iPSC (Fig. 4,
clusters 4 and 6). These proteins may point to mechanisms
involved in the stabilization of these cells towards a mature
ES-like phenotype (Supplementary Fig. 3). Numerous proteins
involved in post-transcriptional (mRNA splicing) and post-
translational (ubiquitin-mediated proteolysis) regulation were
grouped in cluster 4. Also, several proteins known to activate
either the canonical and non-canonical Wnt pathway were
present in the same cluster, which is in agreement with the
upregulation of beta-catenin in low-dox cells compared with
F-class (Supplementary Fig. 5). Predicted upstream TFs for the
members of this cluster included the chromatin modifier enzyme
Crem and Erg, as well as Zfx, known to control self-renewal49.
Our proteomics data, in conjunction with the in-parallel-
generated complementary -omics data38, represents a unique
resource to further study the molecular mechanisms of the
reprogramming process. To the best of our knowledge, this
analysis represents the most comprehensive proteomic profiling
of the reprogramming process, both in terms of its temporal
resolution and its cellular outcomes characterization. We
confirmed the processes involved in the early transition recently
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published in gene expression and proteomic analyses28,36,
suggesting that they represent well-defined features of the early
step of reprogramming regardless of the system used to generate
iPSCs or the cellular subpopulation selected for the analysis. In
addition, we were able to define and isolate two different
reprogramming routes leading to the F-class37 and ESC-like state
through a dual transgene expression scheme (Fig. 1). Our
analyses indeed revealed a second wave of global proteome
adaptation occurring in two distinct pluripotent cellular
populations both of which involved activation of Nanog but
showed differences in adhesion properties, cell metabolism and
gene expression control. Therefore, our experimental design and
data set represent an ideal system to capture and characterize
multiple routes leading to pluripotency.
Methods
Cell culture and secondary reprogramming. ESCs and iPSCs were cultured in
5% CO2 at 37 C on irradiated MEFs in DMEM containing 15% FCS, leukemia-
inhibiting factor, penicillin/streptomycin, L-glutamine, nonessential amino acids,
sodium pyruvate and 2-mercaptoethanol. 1B 1 iPS cells were aggregated with
tetraploid host embryos as described27 and MEFs established from E13.5 embryos.
Fibroblasts were expanded to passage three with one billion fibroblasts forming the
basis of the reprogramming system. Cell reprogramming was induced by exposure
to 1,500 ngml 1 doxycycline (dox). Reprogramming cells were maintained as two
parallel cultures passaged on alternate days (three day intervals), to ensure that
biological samples were consistently collected 48 h after passaging. Cell
reprogramming was induced by exposure to 1,500 ngml 1 doxycycline (dox).
Reprogramming cells were maintained as two parallel cultures passaged on
alternate days (three day intervals), to ensure that biological samples were
consistently collected 48 h after passaging. High doxycycline cell samples were
collected at days 0, 2, 5, 8, 11, 16 and 18 (D2H, D5H, D8H, D11H, D16H, D18H).
A subculture of the reprogramming cells was established from day 19 and cultured
in the absence of dox, to develop a factor-independent 2 iPS cell line by day 30
(2iPSC). Low-dox samples were maintained from day 8 to day 14 cells in 5 ng dox.
At day 14, the culture was diverged in two with some of the cells being cultured
until day 21 in the absence of dox (D21Ø) and the remainder were cultured in
5 ngml 1 of dox and collected at day 16 (D16L) and day 21 (D21L). Rosa26-rtTA
ESCs and 1B 1o iPSCs were collected as controls.
Sample preparation for MS analysis. Secondary MEFs, primary and secondary
miPSCs, mESCs, six intermediate reprogramming time points in high-dox
conditions (D2H, D5H, D8H, D11H, D16H and D18H) and three intermediate
reprogramming time points in low-dox conditions (D16L, D21L, D21Ø) were
collected by centrifugation at 2,500 g for 10min at 4 C. Cell lysis was performed in
a buffer containing 8M urea in a solution of 100mM triethyl ammonium bicar-
bonate (Fluka), pH 8.2, with protease and phosphatase inhibitors (Roche). Proteins
(B1mg) were first reduced/alkylated and digested for 4 h with Lys-C. The mixture
was then diluted fourfold to 2M urea and digested overnight with sequencing-
grade trypsin (Promega) in substrate/enzyme ratio of 50:1 (w/w). Digestion was
quenched by acidification with formic acid (FA) (final concentration 10%).
Resulting peptides were subsequently desalted by solid phase extraction (Sep-pack
Vac C18 cartridges, Waters), vacuum dried and then re-suspended in triethyl
ammonium bicarbonate buffer 100mM to a final concentration of B1mgml 1.
An aliquot of 100mg of each sample was chemically labelled with Tandem Mass
Tag (TMT) reagents50 (Thermo Fisher) according to the manufacturer’s
instructions. To accommodate all the 13 samples in the analysis, three TMT
mixtures were created. Basically, ‘mix1’ contained a set of five different samples
mixed in a 1:1 ratio (secondary MEFs and day 2, 5, 8 and 11). ‘Mix2’ contained the
other set of samples mixed in a 1:1 ratio (D16H, D18H, ESC, 1iPSCs and
2iPSCs). ‘Mix3’ contains the low-dox samples mixed in a 1:1 ratio. An internal
standard consisting of a mixture in a 1:1 ratio of all the samples included in mix1
and 2 (labelled with TMT reagent 126) was also included in ‘Mix1’, ‘Mix2’ and
‘Mix3’. This internal standard was used for data normalization and integration of
both data sets (Supplementary Fig.1). Before the mass spectrometric analysis, both
the TMT-labelled peptides mixtures were fractionated as described elsewhere51.
The SCX system consisted of an Agilent 1200 HPLC system (Agilent Technologies,
Waldbronn, Germany) with one C18 Opti-Lynx (Optimized Technologies, OR)
trapping cartridges and a Zorbax BioSCX-Series II column (0.8-mm inner
diameter, 50-mm length, 3.5microms particle size). The labelled peptides were
dissolved in 10% FA and loaded onto the trap columns at 100 ml min 1 and
subsequently eluted onto the SCX column with 80% acetonitrile (ACN; Biosolve,
The Netherlands) and 0.05% FA. SCX solvent A consists of 0.05% formic acid in
20% ACN, while solvent B was 0.05% formic acid, 0.5M NaCl in 20% ACN. The
SCX salt gradient is as follows: 0–0.01min (0–2% B); 0.01–8.01min (2–3% B);
8.01–14.01min (3–8% B); 14.01–28min (8–20% B); 28–38min (20–40% B); 38–
48min (40–90% B); 48–54min (90% B); 54–60min (0% B). A total of 50 SCX
fractions (1min each, that is, 40 ml elution volume) were collected and used for
subsequent LC-MS/MS analysis.
Mass spectrometric analysis. We performed nanoflow LC-MS/MS using an
LTQ-Orbitrap Velos mass spectrometer (Thermo Electron, Bremen, Germany)
coupled to an Agilent 1200 HPLC system (Agilent Technologies). SCX fractions
were dried, reconstituted in 10% FA and delivered to a trap column (ReproSil C18,
(Dr Maisch GmbH, Ammerbuch, Germany); 20mm 100 mm inner diameter,
packed in-house) at 5 ml min 1 in 100% solvent A (0.1M acetic acid in water).
Next, peptides eluted from the trap column onto an analytical column (ReproSil-
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Pur C18-AQ (Dr Maisch GmbH, Ammerbuch, Germany); 40 cm length, 50 mm
inner diameter, packed in-house) at B100 nlmin 1 in a 90min or 3 h gradient
from 0–40% solvent B (0.1M acetic acid in 8:2 (v/v) ACN/water). The eluent was
sprayed via distal coated emitter tips butt-connected to the analytical column. The
mass spectrometer was operated in data-dependent mode, automatically switching
between MS and MS/MS. Full-scan MS spectra (from m/z 350–1,500) were
acquired in the Orbitrap with a resolution of 30,000 FHMW at 400m/z after
accumulation to target value of 500,000 in the linear ion trap (maximum injection
time was 250ms). After the survey scans, the 10 most intense precursor ions at a
threshold above 5,000 were selected for MS/MS with an isolation width of 1.2 Da
after accumulation to a target value of 30,000 (maximum injection time was 50ms).
Peptide fragmentation was carried out by using higher-energy collisional dis-
sociation with an activation time of 0.1ms and a normalized collision energy of
45%. Fragment ions analysis was performed in the Orbitrap with a resolution of
7,500 FHMW and a low mass cut-off setting of 100m/z. Each SCX fraction was
analysed at least in triplicate, with a 90min or 3 h LC gradient, depending on their
complexity.
Data processing. MS raw data were processed with Proteome Discoverer
(version 1.3, Thermo Electron). Basically, peptide identification was performed
with Mascot 2.3 (Matrix Science) against a concatenated forward-decoy UniPROT
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database supplemented with all the frequently observed contaminants in MS
(version 5.62). The following parameters were used: 50 p.p.m. precursor
mass tolerance, 0.02Da fragment ion tolerance, up to two missed cleavages,
carbamidomethyl cysteine as fixed modification, oxidized methionine and TMT
modification on amino (N)-term and Lysine as variable modifications. Finally, we
performed a deconvolution of the high-resolution MS2 spectra, by which all the
fragment ions isotopic distributions were converted to an m/z value corresponding
to the monoisotopic single charge. Reporter ion-based quantification method was
chosen in Proteome Discoverer, with the following requirements for reporter ion
integration in the MS2 spectra; mass accuracy of maximum 20 p.p.m., peptide ratio
maximum limit 100. To minimize ratio distortion due to the presence of more than
one peptide species within the precursor ion isolation width, we also reject the
quantification of MS/MS spectra having a co-isolation higher than 30%. Finally,
results were filtered using the following criteria: (i) mass deviations of ±5 p.p.m.,
(ii) Mascot Ion Score of at least 25, (iii) a minimum of seven amino-acid residues
per peptide and (iv) position rank 1 in Mascot search. As a result, we obtained
peptide FDRs52 below 1% for all of the three peptide mixtures analysed
(Supplementary Data 1). Finally, peptide ratios were Log2 transformed and
normalized by median subtraction.
Bioinformatic analysis. Pearson’s correlation heatmaps and hierarchical cluster-
ing were generated using the MeV software53. Protein profiles were grouped
through a soft clustering approach (Fig. 2), implemented in the GProx open source
software package54. To this end, only proteins showing at least a fold change higher
±1 (in Log2 scale) compared with the 2MEF in at least one time point were used
(Supplementary Data 2). Protein expression values were then standardized to have
a mean value of zero and a standard deviation of one, ensuring that vectors of
proteins with similar expression changes are close in Euclidean space. Clustering
parameters such as Fuzzification, memberhip threshold and number of clusters
were set at 1.45, 0.5 and 9, respectively. The protein members of each cluster were
then subjected for functional analyses (that is, enrichment of GO terms,
transcription factor binding and miRNAs prediction) using X2K software55.
Statistical tests combining P value and z-score were used to detect
overrepresentation of the annotations included in either GO, KEGG and CheA
database. Transcription factor networks were created through the software
TVNviewer56. Ingenuity Pathway Analysis was used to evaluate the enrichment of
certain biological classes in protein with weak RNA to protein correlation. The
processed proteomics data can be viewed alongside mRNA, miRNA, DNA
methylation and histone mark analyses, on the same set of samples38–40, at
www.stemformatics.org. This open-access resource allows collating, visualizing and
analysing several large-scale data sets related to pluripotency. Pearson’s correlation
heatmaps were generated using the MeV software. Functional analyses (that is,
enrichment of GO terms, transcription factor binding) were done with the X2K
software55. Statistical tests combining P value and z-score were used to detect
overrepresentation of the annotations included in either GO, KEGG and CheA
databases. Transcription factor networks were created with the software
TVNviewer56.
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